Literature DB >> 23121625

Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient.

K Neemann1, D D Eichele, P W Smith, R Bociek, M Akhtari, A Freifeld.   

Abstract

We present a case of severe Clostridium difficile infection (CDI) in a non-neutropenic allogeneic hematopoietic stem cell transplant recipient who was treated successfully with fecal microbiota therapy after standard pharmacologic therapy had failed. Following naso-jejunal instillation of donor stool, the patient's symptoms resolved within 48 h. Bowel resection was averted. This is the first case in the literature, to our knowledge, to describe fecal microbiota therapy in a profoundly immunocompromised host with severe CDI. We propose that fecal microbiota therapy be considered as a therapeutic option in immunosuppressed patients with refractory severe CDI.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 23121625     DOI: 10.1111/tid.12017

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  39 in total

Review 1.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

2.  Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma.

Authors:  C Mittal; N Miller; A Meighani; B R Hart; A John; M Ramesh
Journal:  Bone Marrow Transplant       Date:  2015-04-20       Impact factor: 5.483

3.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

Review 4.  Clostridium difficile infection in patients with HIV/AIDS.

Authors:  Paul J Collini; Ed Kuijper; David H Dockrell
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

5.  Fecal microbiota transplant after hematopoietic SCT: report of a successful case.

Authors:  C G de Castro; A J Ganc; R L Ganc; M S Petrolli; N Hamerschlack
Journal:  Bone Marrow Transplant       Date:  2014-09-29       Impact factor: 5.483

Review 6.  Gut microbiota and hematopoietic stem cell transplantation: where do we stand?

Authors:  D Zama; E Biagi; R Masetti; P Gasperini; A Prete; M Candela; P Brigidi; A Pession
Journal:  Bone Marrow Transplant       Date:  2016-06-27       Impact factor: 5.483

7.  Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

Authors:  Zachariah DeFilipp; Jonathan U Peled; Shuli Li; Jasmin Mahabamunuge; Zeina Dagher; Ann E Slingerland; Candice Del Rio; Betsy Valles; Maria E Kempner; Melissa Smith; Jami Brown; Bimalangshu R Dey; Areej El-Jawahri; Steven L McAfee; Thomas R Spitzer; Karen K Ballen; Anthony D Sung; Tara E Dalton; Julia A Messina; Katja Dettmer; Gerhard Liebisch; Peter Oefner; Ying Taur; Eric G Pamer; Ernst Holler; Michael K Mansour; Marcel R M van den Brink; Elizabeth Hohmann; Robert R Jenq; Yi-Bin Chen
Journal:  Blood Adv       Date:  2018-04-10

8.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults.

Authors:  Krishna Rao; Kavitha Santhosh; Jill A Mogle; Peter D R Higgins; Vincent B Young
Journal:  Infect Dis (Lond)       Date:  2016-05-20

Review 9.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

10.  Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection.

Authors:  Hadeel Zainah; Mona Hassan; Laila Shiekh-Sroujieh; Syed Hassan; George Alangaden; Mayur Ramesh
Journal:  Dig Dis Sci       Date:  2014-07-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.